Aura Biosciences Inc's market cap is currently $381.13M. The company's EPS TTM is $-1.73; its P/E ratio is ―; Aura Biosciences Inc is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.29M	$ -1.18M	$ -835.00K	$ -831.00K	$ -509.00K
Operating Income	$ -84.99M	$ -60.30M	$ -35.25M	$ -22.21M	$ -24.14M
EBITDA	$ -83.70M	$ -59.12M	$ -34.42M	$ -21.38M	$ -23.63M
Net Income	$ -76.41M	$ -57.23M	$ -34.42M	$ -22.21M	$ -24.20M
Balance Sheet
Cash & Short-Term Investments	$ 226.15M	$ 188.81M	$ 149.06M	$ 17.39M	$ 32.45M
Total Assets	$ 255.07M	$ 223.94M	$ 160.03M	$ 22.10M	$ 37.05M
Total Debt	$ 19.56M	$ 20.86M	$ 975.00K	$ 15.00K	$ 49.00K
Net Debt	$ -21.51M	$ -100.72M	$ -148.09M	$ -17.38M	$ -32.40M
Total Liabilities	$ 29.23M	$ 28.35M	$ 7.71M	$ 130.82M	$ 124.46M
Stockholders' Equity	$ 225.85M	$ 195.58M	$ 152.31M	$ -108.71M	$ -87.41M
Cash Flow
Free Cash Flow	$ -64.56M	$ -55.70M	$ -34.53M	$ -25.09M	$ -22.89M
Operating Cash Flow	$ -63.85M	$ -54.60M	$ -32.41M	$ -24.32M	$ -20.67M
Investing Cash Flow	$ -113.96M	$ -67.87M	$ -2.13M	$ -771.00K	$ -2.22M
Financing Cash Flow	$ 97.29M	$ 95.63M	$ 166.26M	$ 10.04M	$ 39.73M

Currency in USD

Aura Biosciences Inc Earnings and Revenue History

Income Statement >

Aura Biosciences Inc Debt to Assets

Balance Sheet >

Aura Biosciences Inc Cash Flow

Cash Flow >

Aura Biosciences Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing